Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
Isaac Okello, Global Genes Leadership Council Member, shared a post on LinkedIn:
“What is built with purpose never goes to waste.
Forged through years of advocacy, resilience, partnership, and collective action Raising Hope International Friends, member organization of the Sickle Cell Alliance Uganda (SCAU) is stepping into its next chapter with renewed strength, purpose, and determination to advance sickle cell advocacy in Uganda.
We are particularly excited and grateful for the leadership of the State Minister for Health in Charge of Primary Health Care, who convened this important advocacy meeting, bringing together key stakeholders and partners committed to strengthening the national sickle cell response.
The meeting provided an important platform for dialogue, policy engagement, and collective action towards sustainable financing and improved services for people and families affected by sickle cell disease.
We extend our sincere appreciation to Novo Nordisk Haemophilia and Haemoglobinopathies Foundation for continued support towards strengthening sickle cell programming and advocacy in Uganda.”
Other posts featuring Isaac Okello on Hemostasis Today.
-
Sep 23, 2026, 04:34David Akande: When Sickle Cell Crises Have No Clear Trigger
-
Sep 23, 2026, 04:13Jean Connors: Safety of Heparin Re-Exposure in Patients with Remote HIT
-
Sep 23, 2026, 04:09Beth Psaila: Applications Now Open for the Gordon Research Conference on Megakaryocytes and Platelets
-
Sep 23, 2026, 03:27Abbie Newton: How Better Data Can Reduce Platelet Wastage
-
Sep 23, 2026, 03:01Suvro Sankha Datta: Rapid Blood Group Genotyping Using Gold Oligo Nanonet Assembly
-
Sep 23, 2026, 02:55Asghar Muhammad: Exploring New Ways to Expand Blood Transfusion Compatibility
-
Sep 23, 2026, 02:49Bianca Rocca: Personalized Cardiovascular Pharmacotherapy in the September 2026 EHJ Issue
-
Sep 23, 2026, 02:35Udaya RajBhandari: A Hidden Risk of Repeated Transfusions in β Thalassemia
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy